DE60111905D1 - Adenosine als Antithrombosemittel - Google Patents

Adenosine als Antithrombosemittel

Info

Publication number
DE60111905D1
DE60111905D1 DE60111905T DE60111905T DE60111905D1 DE 60111905 D1 DE60111905 D1 DE 60111905D1 DE 60111905 T DE60111905 T DE 60111905T DE 60111905 T DE60111905 T DE 60111905T DE 60111905 D1 DE60111905 D1 DE 60111905D1
Authority
DE
Germany
Prior art keywords
biologically active
extract
plant
novel method
active ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111905T
Other languages
English (en)
Inventor
Su-Chen Chang
Li-Wei Hsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Gene Technology Corp
Original Assignee
Advanced Gene Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Gene Technology Corp filed Critical Advanced Gene Technology Corp
Application granted granted Critical
Publication of DE60111905D1 publication Critical patent/DE60111905D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE60111905T 2000-11-07 2001-05-29 Adenosine als Antithrombosemittel Expired - Lifetime DE60111905D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70830600A 2000-11-07 2000-11-07

Publications (1)

Publication Number Publication Date
DE60111905D1 true DE60111905D1 (de) 2005-08-18

Family

ID=24845266

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60111906T Expired - Lifetime DE60111906D1 (de) 2000-11-07 2001-05-03 Verfahren zum Screenen von Pflanzenextrakten nach Wirkstoffen
DE60111905T Expired - Lifetime DE60111905D1 (de) 2000-11-07 2001-05-29 Adenosine als Antithrombosemittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60111906T Expired - Lifetime DE60111906D1 (de) 2000-11-07 2001-05-03 Verfahren zum Screenen von Pflanzenextrakten nach Wirkstoffen

Country Status (7)

Country Link
US (1) US20020082241A1 (de)
EP (2) EP1205754B1 (de)
CN (2) CN1352945A (de)
AT (2) ATE299593T1 (de)
AU (1) AU5178801A (de)
CA (1) CA2348845A1 (de)
DE (2) DE60111906D1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855343B2 (en) * 2002-05-21 2005-02-15 Advanced Gene Technology, Corp Method to ascertain the quality of herbs
CN106501415A (zh) * 2016-12-02 2017-03-15 丽珠集团丽珠制药厂 一种阿魏酸钠、阿司匹林、桂利嗪和维生素b1的含量测定方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
CA2073696A1 (en) * 1990-02-02 1991-08-03 Peter L. Barker Cyclic peptides containing arg-gly-asp flanked by proline
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
JP3002903B2 (ja) * 1991-04-09 2000-01-24 第一化学薬品株式会社 血管外血液の抗凝固・抗血小板剤組成物及びこれを用いる血小板活性化の分子マーカーの測定法
US6137002A (en) * 1993-07-22 2000-10-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
IL121272A (en) * 1997-07-10 2000-06-01 Can Fite Technologies Ltd Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
DE19802576B4 (de) * 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
US6713309B1 (en) * 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture

Also Published As

Publication number Publication date
AU5178801A (en) 2002-05-09
EP1205754B1 (de) 2005-07-13
US20020082241A1 (en) 2002-06-27
EP1205182A3 (de) 2002-09-04
CN1220060C (zh) 2005-09-21
EP1205754A3 (de) 2002-07-17
EP1205182B1 (de) 2005-07-13
CA2348845A1 (en) 2002-05-07
ATE299374T1 (de) 2005-07-15
CN1353003A (zh) 2002-06-12
ATE299593T1 (de) 2005-07-15
EP1205182A2 (de) 2002-05-15
CN1352945A (zh) 2002-06-12
DE60111906D1 (de) 2005-08-18
EP1205754A2 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
IS2508B (is) Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir
ATE340870T1 (de) Adressierbare protein arrays
MEP32608A (en) Antibodies to opgl
DE60231651D1 (de) Proteinreinigungsverfahren
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
DE69610716T2 (de) Topiramate-immunoassay, sowie analoge und antikörper
Elovson Biogenesis of plasma membrane glycoproteins. Purification and properties of two rat liver plasma membrane glycoproteins.
HUP9903841A2 (hu) Eljárás oldatok frakcionálására szimulált mozgóágyas kromatográfiás eljárással
BR9407422A (pt) Kit de ensaio
Uraipong et al. 17β-Estradiol residues and estrogenic activities in the Hawkesbury River, Australia
DK1238284T3 (da) Diagnostisk bestemmelse af slagtilfælde
CN103900893A (zh) 富集乙酰化修饰的蛋白质的试剂盒及方法和应用
DE60111905D1 (de) Adenosine als Antithrombosemittel
Kirtland et al. Novel salvage of queuine from queuosine and absence of queuine synthesis in Chlorella pyrenoidosa and Chlamydomonas reinhardtii
AU5406800A (en) Method for carrying out the chromatographic fractionation of plasma or serum, preparations obtained thereby and their use
Accomazzo et al. Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects
Pillmoor Carbocyclic coformycin: a case study of the opportunities and pitfalls in the industrial search for new agrochemicals from nature
ZA925621B (en) Measurement of an enzyme marker as an aid to diagnosis
Zheljazkov et al. Podophyllotoxin concentration in junipers in the Big Horn Mountains in Wyoming
Legrand et al. Two structural types of ciguatoxins involved on ciguatera fish poisoning in French Polynesia
Doumas et al. Evidence of cytokinin bases, ribosides and glucosides in roots of Douglas-fir, Pseudotsuga menziesii
Hakki et al. A 56 kDa binding protein for Escherichia coli heat-stable enterotoxin isolated from the cytoskeleton of rat intestinal membranes does not possess guanylate cyclase activity
McKeown-Longo et al. Preparation and characterization of an antiserum against purified proteoglycan link proteins from avian cartilage
Odén et al. Detection and identification of gibberellins in extracts of Begonia leaves by bioassay, radioimmunoassay and gas chromatography–mass spectrometry

Legal Events

Date Code Title Description
8332 No legal effect for de